EPM
LLY icon

Equitec Proprietary Markets’s Eli Lilly LLY Stock Holding History

Equitec Proprietary Markets’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-500
Closed -$138K – 347
2021
Q4 		$138K Buy
+500
New +$127K 0.02% 131
2015
Q1 		– Sell
-8,846
Closed -$610K – 371
2014
Q4 		$610K Buy
+8,846
New +$597K 0.03% 138

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Equitec Proprietary Markets's LLY Position: Q1 2022 in Review

Equitec Proprietary Markets sold out of Eli Lilly (LLY) in Q1 2022, closing a stake of 500 shares — an estimated $138K sold.

Equitec Proprietary Markets first reported a position in LLY in Q4 2014 and held it in 2 quarters. The position peaked at $610K in Q4 2014. 2,345 funds tracked by Wall St. Rank hold LLY as of Q1 2022.

  • Equitec Proprietary Markets reported no remaining Eli Lilly position as of Q1 2022 after selling out during the quarter.
  • Equitec Proprietary Markets sold 500 Eli Lilly shares in Q1 2022, an estimated $138K.
  • Equitec Proprietary Markets first reported a position in Eli Lilly in Q4 2014 and held it in 2 quarters.
  • Equitec Proprietary Markets's Eli Lilly position peaked at $610K in Q4 2014.
  • 2,345 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.

Based on Equitec Proprietary Markets's 13F filing for Q1 2022, filed 22 Apr 2022.